Radka Lohynska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Radka Lohynska has a total of 146 co-authors. Here are the top co-authors by number of shared publications:
- Steven E. Schild
Mayo Clinic
11 shared publications - Dirk Rades
Department of Radiation Oncology, University of Luebeck, 23562 Luebeck, Germany
9 shared publications Theo Veninga
9 shared publications- Gedske Daugaard
Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
5 shared publications Juergen Dunst
5 shared publications- Kelly-Anne Phillips
Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
5 shared publications
Latest Publications
- 1 January 2019
- Published by AEPress, s.r.o. in Neoplasma
- Vol. 66 (05) , 830-838
Three-dimensional conformal radiotherapy versus intensity modulated radiotherapy with simultaneous integrated boost in the treatment of locally advanced head and neck carcinoma
Three-dimensional conformal radiotherapy versus intensity modulated radiotherapy with simultaneous integrated boost in the treatment of locally advanced head and neck carcinoma
- 1 January 2019
- Published by AEPress, s.r.o. in Neoplasma
- Vol. 66 (05) , 830-838
Three-dimensional conformal radiotherapy versus intensity modulated radiotherapy with simultaneous integrated boost in the treatment of locally advanced head and neck carcinoma
Three-dimensional conformal radiotherapy versus intensity modulated radiotherapy with simultaneous integrated boost in the treatment of locally advanced head and neck carcinoma
- 1 November 2013
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 109 (2) , 335
Erratum to “A new survival score for patients with brain metastases who received whole-brain radiotherapy (WBRT) alone” [Radiother Oncol 108 (2013) 123–127]
- 1 November 2013
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 109 (2) , 335
Erratum to “A new survival score for patients with brain metastases who received whole-brain radiotherapy (WBRT) alone” [Radiother Oncol 108 (2013) 123–127]
- 30 July 2013
- Published by Wiley in Head & Neck
- Vol. 36 (6) , 763-767
Effectiveness of transoral laser microsurgery for precancerous lesions and early glottic cancer guided by analysis of voice quality
Background The purpose of this study was to show our comparison of the quality of voice obtained after superficial transoral endoscopic cordectomies (types I, II, and III) according to the European Laryngological Society classification versus the more extended cordectomy (types IV and V) among patients with glottic precancerous lesions or early glottic cancer. Methods Sixty‐two patients underwent vocal assessment after cordectomy (types I–V) for dysplasia, Tis, T1a, T1b, and T2 lesions. Results Cordectomy (types I–III) had good vocal outcomes. Cordectomy (types IV–V) showed less favorable outcomes, p < .005 in common parameters of voice range profile and symmetry in stroboscopy after cordectomy (types IV–V), with significant voice handicap index. Recurrences were found in 4 patients with T1b and T2 cancer. Two cases were managed by a higher type of cordectomy, and the other 2 by total laryngectomy. Conclusion Effect of transoral laser microsurgery on quality of voice depends on the type of cordectomy and the site of the lesion. © 2013 Wiley Periodicals, Inc. Head Neck 36: 763–767, 2014
- 30 July 2013
- Published by Wiley in Head & Neck
- Vol. 36 (6) , 763-767
Effectiveness of transoral laser microsurgery for precancerous lesions and early glottic cancer guided by analysis of voice quality
Background The purpose of this study was to show our comparison of the quality of voice obtained after superficial transoral endoscopic cordectomies (types I, II, and III) according to the European Laryngological Society classification versus the more extended cordectomy (types IV and V) among patients with glottic precancerous lesions or early glottic cancer. Methods Sixty‐two patients underwent vocal assessment after cordectomy (types I–V) for dysplasia, Tis, T1a, T1b, and T2 lesions. Results Cordectomy (types I–III) had good vocal outcomes. Cordectomy (types IV–V) showed less favorable outcomes, p < .005 in common parameters of voice range profile and symmetry in stroboscopy after cordectomy (types IV–V), with significant voice handicap index. Recurrences were found in 4 patients with T1b and T2 cancer. Two cases were managed by a higher type of cordectomy, and the other 2 by total laryngectomy. Conclusion Effect of transoral laser microsurgery on quality of voice depends on the type of cordectomy and the site of the lesion. © 2013 Wiley Periodicals, Inc. Head Neck 36: 763–767, 2014
- 1 July 2013
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 108 (1) , 123-127
A new survival score for patients with brain metastases who received whole-brain radiotherapy (WBRT) alone
- 1 July 2013
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 108 (1) , 123-127
A new survival score for patients with brain metastases who received whole-brain radiotherapy (WBRT) alone
- Open Access
Dose‐escalation of whole‐brain radiotherapy for brain metastasis in patients with a favorable survival prognosis
BACKGROUND: Patients with brain metastases who have a favorable survival prognosis may benefit from intensive treatments, including neurosurgery and radiosurgery. However, many patients cannot receive such treatments, and whole‐brain radiotherapy (WBRT) alone is their only option. The most common WBRT schedule is 30 grays (Gy) in 10 fractions. In this retrospective study, the authors investigated whether these patients benefit from a dose escalation beyond 30 Gy. METHODS: Data from 109 patients who received 30 Gy in 10 fractions were compared with 75 patients who received 40 Gy in 20 fractions. All patients had a favorable survival prognosis. Both groups were compared for local control (LC) and overall survival (OS). Subgroup analyses were performed for patients who had less radiosensitive tumors (N = 27) and for other patients (N = 157). RESULTS: The LC rate at 1 year was 28% after 30 Gy and 44% after 40 Gy (P = .064). On multivariate analysis, the 40 Gy dose was associated with improved LC (P = .047). The survival rate at 1 year was 50% after 30 Gy and 61% after 40 Gy (P = .007). On multivariate analysis, the 40 Gy dose was associated with improved OS (P = .008). On subgroup analysis of patients who had less radiosensitive tumors, the 1‐year LC rate was 7% after 30 Gy and 38% after 40 Gy (P = .031); and the 1‐year OS rate was 40% and 73%, respectively (P = .008). On subgroup analysis of patients who had other tumor types, the 1‐year LC rate was 31% after 30 Gy and 45% after 40 Gy (P = .26); and the 1‐year OS rate was 52% and 59%, respectively (P = .08). CONCLUSIONS: Escalation of the WBRT dose beyond 30 Gy resulted in better outcomes, particularly for patients who had less radiosensitive tumors. Cancer 2012. © 2011 American Cancer Society.
Open AccessDose‐escalation of whole‐brain radiotherapy for brain metastasis in patients with a favorable survival prognosis
BACKGROUND: Patients with brain metastases who have a favorable survival prognosis may benefit from intensive treatments, including neurosurgery and radiosurgery. However, many patients cannot receive such treatments, and whole‐brain radiotherapy (WBRT) alone is their only option. The most common WBRT schedule is 30 grays (Gy) in 10 fractions. In this retrospective study, the authors investigated whether these patients benefit from a dose escalation beyond 30 Gy. METHODS: Data from 109 patients who received 30 Gy in 10 fractions were compared with 75 patients who received 40 Gy in 20 fractions. All patients had a favorable survival prognosis. Both groups were compared for local control (LC) and overall survival (OS). Subgroup analyses were performed for patients who had less radiosensitive tumors (N = 27) and for other patients (N = 157). RESULTS: The LC rate at 1 year was 28% after 30 Gy and 44% after 40 Gy (P = .064). On multivariate analysis, the 40 Gy dose was associated with improved LC (P = .047). The survival rate at 1 year was 50% after 30 Gy and 61% after 40 Gy (P = .007). On multivariate analysis, the 40 Gy dose was associated with improved OS (P = .008). On subgroup analysis of patients who had less radiosensitive tumors, the 1‐year LC rate was 7% after 30 Gy and 38% after 40 Gy (P = .031); and the 1‐year OS rate was 40% and 73%, respectively (P = .008). On subgroup analysis of patients who had other tumor types, the 1‐year LC rate was 31% after 30 Gy and 45% after 40 Gy (P = .26); and the 1‐year OS rate was 52% and 59%, respectively (P = .08). CONCLUSIONS: Escalation of the WBRT dose beyond 30 Gy resulted in better outcomes, particularly for patients who had less radiosensitive tumors. Cancer 2012. © 2011 American Cancer Society.
- 1 July 2011
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 80 (4) , 1122-1127
Scoring Systems to Estimate Intracerebral Control and Survival Rates of Patients Irradiated for Brain Metastases
- 1 July 2011
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 80 (4) , 1122-1127
Scoring Systems to Estimate Intracerebral Control and Survival Rates of Patients Irradiated for Brain Metastases
- 7 April 2011
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 81 (4) , e469-e473
Shorter-Course Whole-Brain Radiotherapy for Brain Metastases in Elderly Patients
- 7 April 2011
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 81 (4) , e469-e473
Shorter-Course Whole-Brain Radiotherapy for Brain Metastases in Elderly Patients
- 1 September 2010
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 28 (5) , 492-499
The International Testicular Cancer Linkage Consortium: A clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindred
- 1 September 2010
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 28 (5) , 492-499
The International Testicular Cancer Linkage Consortium: A clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindred
- 1 April 2010
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 112 (3) , 183-187
Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC)
- 1 April 2010
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 112 (3) , 183-187
Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC)
- 1 April 2008
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 70 (5) , 1319-1324
Surgical Resection Followed by Whole Brain Radiotherapy Versus Whole Brain Radiotherapy Alone for Single Brain Metastasis
- 1 April 2008
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 70 (5) , 1319-1324
Surgical Resection Followed by Whole Brain Radiotherapy Versus Whole Brain Radiotherapy Alone for Single Brain Metastasis